Identifiability and selection bias in indirect comparisons using real-world controls: a systematic review of methods and reporting
Open Access
- 4 May 2026
- journal article
- review article
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 196, 112301
Abstract
No abstract availableKeywords
Funding Information
- Agence Nationale de la Recherche (ANR-22-PESN-0003)
This publication has 41 references indexed in Scilit:
- Externally Controlled Studies Using Real-World Data in Patients With Hematological CancersJAMA Oncology, 2024
- Clinical Benefit and Regulatory Outcomes of Cancer Drugs Receiving Accelerated ApprovalJAMA, 2024
- Effectively Leveraging RWD for External Controls: A Systematic Literature Review of Regulatory and HTA DecisionsClinical Pharmacology & Therapeutics, 2023
- Target Trial EmulationJAMA, 2022
- Propensity score methods for observational studies with clustered data: A reviewStatistics in Medicine, 2022
- Understanding Use of Real‐World Data and Real‐World Evidence to Support Regulatory Decisions on Medical Product EffectivenessClinical Pharmacology & Therapeutics, 2021
- Methods for external control groups for single arm trials or long‐term uncontrolled extensions to randomized clinical trialsPharmacoepidemiology and Drug Safety, 2020
- A Framework for Methodological Choice and Evidence Assessment for Studies Using External Comparators from Real-World DataDrug Safety, 2020
- Using Electronic Health Records to Derive Control Arms for Early Phase Single‐Arm Lung Cancer Trials: Proof‐of‐Concept in Randomized Controlled TrialsClinical Pharmacology & Therapeutics, 2019
- Assessment of the Clinical Benefit of Cancer Drugs Receiving Accelerated ApprovalJAMA Internal Medicine, 2019